Helix BioPharma (HBP) Competitors C$1.02 +0.01 (+0.99%) As of 10:08 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock HBP vs. BCT, IPA, TH, ONC, SCYB, COM, NVH, APS, IGX, and COVShould you be buying Helix BioPharma stock or one of its competitors? The main competitors of Helix BioPharma include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Theratechnologies (TH), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), Aptose Biosciences (APS), IntelGenx Technologies (IGX), and Covalon Technologies (COV). These companies are all part of the "biotechnology" industry. Helix BioPharma vs. Its Competitors BriaCell Therapeutics ImmunoPrecise Antibodies Theratechnologies Oncolytics Biotech Scythian Biosciences 138267 (COM.TO) Novoheart Aptose Biosciences IntelGenx Technologies Covalon Technologies Helix BioPharma (TSE:HBP) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability. Is HBP or BCT more profitable? Helix BioPharma's return on equity of 1,803.57% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Helix BioPharmaN/A 1,803.57% -279.98% BriaCell Therapeutics N/A N/A N/A Does the media refer more to HBP or BCT? In the previous week, BriaCell Therapeutics had 2 more articles in the media than Helix BioPharma. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 0 mentions for Helix BioPharma. BriaCell Therapeutics' average media sentiment score of 0.08 beat Helix BioPharma's score of 0.00 indicating that BriaCell Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Helix BioPharma Neutral BriaCell Therapeutics Neutral Which has better earnings and valuation, HBP or BCT? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Helix BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHelix BioPharmaN/AN/A-C$50.55M-C$0.95-1.07BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19 SummaryBriaCell Therapeutics beats Helix BioPharma on 4 of the 6 factors compared between the two stocks. Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HBP vs. The Competition Export to ExcelMetricHelix BioPharmaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$54.08MC$132.44MC$5.51BC$6.28BDividend Yield1.50%3.74%4.00%6.72%P/E Ratio-1.073.6128.1856.54Price / SalesN/A4,457.65426.881,131.10Price / Cash11.3213.1924.9983.29Price / Book-7.3340.738.274.95Net Income-C$50.55M-C$90.99MC$3.24BC$301.20M7 Day Performance5.15%1.63%1.80%0.88%1 Month Performance13.33%6.37%9.32%5.26%1 Year PerformanceN/A178.70%35.12%26.39% Helix BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBPHelix BioPharmaN/AC$1.02+1.0%N/AN/AC$54.08MN/A-1.079High Trading VolumeBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownTHTheratechnologiesN/AC$4.31+0.2%N/A+100.0%C$137.51MC$52.22M-48.79103ONCOncolytics Biotech1.9696 of 5 starsC$1.51-6.2%C$3.50+131.8%+22.7%C$116.38MN/A-4.2129Positive NewsHigh Trading VolumeSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423.50K-13.95N/AAPSAptose BiosciencesN/AC$2.30+12.2%N/A-91.7%C$99.03MN/A-0.4631Gap UpIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpCOVCovalon TechnologiesN/AC$2.56-1.9%N/A+25.1%C$70.14MC$27.87M29.38N/APositive News Related Companies and Tools Related Companies BriaCell Therapeutics Competitors ImmunoPrecise Antibodies Competitors Theratechnologies Competitors Oncolytics Biotech Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors Aptose Biosciences Competitors IntelGenx Technologies Competitors Covalon Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:HBP) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
